Essilor: Publication of the 2014 Interim Financial Report

Regulatory News:

Essilor (Paris:EI):

The Essilor International 2014 Interim Financial Report is being published today.

The report comprises the interim consolidated financial statements, the interim management report, the statement by the person responsible for the interim financial report and the Auditors’ review report on the interim consolidated financial statements.

It can be downloaded from the Company’s website, www.essilor.com, in the "Publications & Downloads” section, or by clicking on:

http://www.essilor.com/en/Investors/Pages/PublicationsDownloads.aspx

About Essilor

The world's leading ophthalmic optics company, Essilor designs, manufactures and markets a wide range of lenses to improve and protect eyesight. Its corporate mission is to enable everyone around the world to access lenses that meet his or her unique vision requirements. To support this mission, the Company allocates more than €150 million to research and innovation every year, in a commitment to continuously bring new, more effective products to market. Essilor's flagship brands are Varilux®, Crizal®, Transitions, Definity®, Xperio®, Optifog™, Foster Grant®, Bolon® and Costa®. It also develops and markets equipment, instruments and services for eyecare professionals. Essilor reported consolidated revenue of over €5 billion in 2013 and employs more than 55,000 people. It operates in some 100 countries with 28 plants, more than 450 prescription laboratories and edging facilities, as well as several research and innovation centers around the world. For more information, please visit www.essilor.com.

The Essilor share trades on the NYSE Euronext Paris market and is included in the Euro Stoxx 50 and CAC 40 indices.
Codes and symbols: ISIN: FR0000121667; Reuters: ESSI.PA; Bloomberg: EI:FP.